John Patrick Connolly, MD
Plastic and Reconstructive Surgery · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 2 carriers
- Offices
- 6
Offices
6 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
2 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Connolly’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
2 of 2 plans
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A84319 · Current
Licensed to practise in California · since 2003 · expires 2028-10-31 · Georgetown University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$41,522
Medicare paid this office $41,522 for 78 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (45+ min) | 33 | $4,944 | $150 |
| Return visit (30+ min) | 24 | $3,571 | $119 |
| Short return visit (20+ min) | 22 | $3,456 | $84 |
| New patient visit (30+ min) | 14 | $1,502 | $107 |
Procedures Medicare counted
| Mastectomy | 19 | More than 77% of doctors who do this |
| Melanoma (skin cancer) excision | 16 | More than 71% of doctors who do this |
| Removal of skin lesions | 1-10 | None |
| Removal or shaving of skin growth | 1-10 | None |
| Skin biopsy | 1-10 | None |
Who their Medicare patients are
78 Original Medicare patients in 2024. Average age 74 · Women 76% · Health risk score 1.08. At or below the middle of the specialty; the typical plastic and reconstructive surgery clinician is at 1.21.
Conditions among them: High blood pressure 60% · Cancer 40% · Diabetes 22% · Coronary heart disease 22% · Chronic kidney disease 15% · Atrial fibrillation 15% · Depression 15% · Heart failure 14%.
The office billed $204,103, Medicare allowed $53,301 and paid $41,522; for 220 services of 31 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 78 | 220 | 74 | 1.08 | $204,103 | $41,522 |
| 2023 | 66 | 220 | 75 | 0.70 | $260,550 | $54,734 |
| 2022 | 81 | 213 | 75 | 0.92 | $195,466 | $44,517 |
| 2021 | 121 | 287 | 74 | 1.01 | $279,513 | $61,521 |
| 2020 | 86 | 202 | 73 | 0.99 | $206,786 | $49,499 |
| 2019 | 80 | 199 | 74 | 1.25 | $246,356 | $57,666 |
| 2018 | 79 | 180 | 74 | 1.31 | $196,793 | $44,652 |
| 2017 | 80 | 255 | 73 | 1.36 | $281,840 | $62,358 |
| 2016 | 82 | 194 | 73 | 1.05 | $206,234 | $46,521 |
| 2015 | 81 | 235 | 72 | 1.14 | $239,277 | $58,925 |
| 2014 | 86 | 228 | 72 | 1.24 | $266,306 | $57,718 |
| 2013 | 72 | 168 | 71 | 1.22 | $185,869 | $44,014 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| New patient visit (45+ min) | 31 | $4,906 | $158 |
| Return visit (30+ min) | 20 | $2,754 | $120 |
| Short return visit (20+ min) | 26 | $2,560 | $80 |
2022: 5 services
| New patient visit (45+ min) | 29 | $4,318 | $149 |
| Return visit (30+ min) | 24 | $3,974 | $120 |
| Short return visit (20+ min) | 20 | $2,224 | $74 |
| New patient visit (30+ min) | 13 | $1,391 | $107 |
| Short return visit | 12 | $774 | $52 |
2021: 5 services
| New patient visit (45+ min) | 39 | $5,988 | $154 |
| Short return visit (20+ min) | 34 | $3,763 | $88 |
| New patient visit (30+ min) | 32 | $3,327 | $104 |
| Return visit (30+ min) | 20 | $2,706 | $123 |
| Short return visit | 11 | $712 | $45 |
2020: 6 services
| New patient visit (30+ min) | 26 | $2,448 | $94 |
| Return visit (30+ min) | 14 | $1,751 | $103 |
| Short return visit (20+ min) | 22 | $1,579 | $61 |
| New patient visit (45+ min) | 11 | $1,491 | $136 |
| New patient visit (15+ min) | 17 | $1,155 | $68 |
| Short return visit | 11 | $460 | $38 |
2019: 5 services
| Short return visit (20+ min) | 26 | $2,302 | $66 |
| New patient visit (30+ min) | 21 | $2,106 | $100 |
| New patient visit (45+ min) | 11 | $1,565 | $142 |
| New patient visit (15+ min) | 21 | $1,412 | $67 |
| Return visit (30+ min) | 11 | $1,362 | $105 |
2018: 5 services
| New patient visit (30+ min) | 21 | $1,857 | $88 |
| Short return visit (20+ min) | 19 | $1,527 | $61 |
| Return visit (30+ min) | 15 | $1,146 | $76 |
| New patient visit (15+ min) | 15 | $1,004 | $67 |
| Short return visit | 14 | $896 | $39 |
2017: 5 services
| Short return visit (20+ min) | 28 | $2,303 | $66 |
| New patient visit (30+ min) | 22 | $1,926 | $88 |
| Return visit (30+ min) | 18 | $1,899 | $95 |
| New patient visit (15+ min) | 19 | $1,224 | $64 |
| Short return visit | 14 | $594 | $35 |
2016: 5 services
| New patient visit (30+ min) | 28 | $2,537 | $91 |
| Return visit (30+ min) | 15 | $1,783 | $99 |
| Short return visit (20+ min) | 22 | $1,563 | $56 |
| New patient visit (15+ min) | 12 | $847 | $71 |
| Short return visit | 14 | $374 | $25 |
2015: 5 services
| Return visit (30+ min) | 23 | $2,741 | $98 |
| Short return visit (20+ min) | 28 | $2,541 | $69 |
| New patient visit (30+ min) | 28 | $2,500 | $89 |
| New patient visit (15+ min) | 13 | $968 | $74 |
| Short return visit | 19 | $687 | $33 |
2014: 4 services
| New patient visit (30+ min) | 30 | $2,861 | $95 |
| Short return visit (20+ min) | 28 | $2,200 | $65 |
| Return visit (30+ min) | 13 | $1,268 | $91 |
| New patient visit (15+ min) | 18 | $1,211 | $67 |
2013: 4 services
| New patient visit (30+ min) | 25 | $2,523 | $101 |
| Return visit (30+ min) | 16 | $1,891 | $86 |
| New patient visit (15+ min) | 18 | $1,269 | $71 |
| Short return visit (20+ min) | 15 | $1,051 | $58 |
Drugs they prescribed that Part D paid
$781
Pharmacies billed $781 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 30% of their Part D prescriptions (29 of 96) in 2024. Above the middle of the specialty; the typical plastic and reconstructive surgery clinician is at 28%.
96 generic and 0 brand-name prescriptions · $781 in drug cost · 42 antibiotic prescriptions to 33 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Cephalexin | 30 | $278 | $8 |
| Hydrocodone-Acetaminophen | 24 | $221 | $8 |
| Ondansetron | 17 | $108 | $6 |
Year by year
| 2024 | 96 | 34 | 30% (29) | 0% | $781 |
| 2023 | 64 | 28 | 33% (21) | None | $615 |
| 2022 | 58 | 26 | 28% (16) | 0% | $647 |
| 2021 | 93 | 36 | 33% (31) | None | $1,571 |
| 2020 | 97 | 29 | 32% (31) | None | $995 |
| 2019 | 38 | 22 | 40% (15) | None | $310 |
| 2018 | 48 | 19 | 29% (14) | None | $1,593 |
| 2017 | 64 | 24 | 44% (28) | 0% | $743 |
| 2016 | 69 | 34 | 28% (19) | None | $2,666 |
| 2015 | 322 | 114 | 10% (33) | 11% | $13,314 |
| 2014 | 232 | 101 | 14% (33) | 8% | $8,987 |
| 2013 | 69 | 35 | 23% (16) | None | $3,483 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Cephalexin | 22 | $195 | $9 |
| Hydrocodone-Acetaminophen | 16 | $126 | $8 |
2022: 2 drugs
| Cephalexin | 20 | $252 | $13 |
| Hydrocodone-Acetaminophen | 13 | $133 | $10 |
2021: 3 drugs
| Cephalexin | 22 | $279 | $13 |
| Hydrocodone-Acetaminophen | 23 | $221 | $10 |
| Ondansetron Odt | 12 | $143 | $12 |
2020: 2 drugs
| Cephalexin | 35 | $312 | $9 |
| Hydrocodone-Acetaminophen | 25 | $189 | $8 |
2019: 2 drugs
| Cephalexin | 12 | $113 | $9 |
| Hydrocodone-Acetaminophen | 12 | $67 | $6 |
2018: 2 drugs
| Hydrocodone-Acetaminophen | 14 | $123 | $9 |
| Cephalexin | 14 | $113 | $8 |
2017: 3 drugs
| Oxycodone-Acetaminophen | 13 | $143 | $11 |
| Cephalexin | 12 | $124 | $10 |
| Hydrocodone-Acetaminophen | 14 | $93 | $7 |
2016: 2 drugs
| Hydrocodone-Acetaminophen | 17 | $182 | $11 |
| Cephalexin | 13 | $126 | $10 |
2015: 7 drugs
| Tamsulosin | 67 | $2,937 | $44 |
| Oxybutynin Chloride Er | 18 | $904 | $50 |
| Finasteride | 48 | $478 | $10 |
| Cephalexin | 48 | $343 | $7 |
| Hydrocodone-Acetaminophen | 27 | $330 | $12 |
| Alfuzosin Hcl Er | 13 | $223 | $17 |
| Ciprofloxacin | 13 | $75 | $6 |
2014: 5 drugs
| Tamsulosin | 54 | $1,182 | $22 |
| Hydrocodone-Acetaminophen | 28 | $304 | $11 |
| Finasteride | 23 | $290 | $13 |
| Cephalexin | 24 | $224 | $9 |
| Ciprofloxacin | 11 | $67 | $6 |
2013: 2 drugs
| Cephalexin | 17 | $217 | $13 |
| Hydrocodone-Acetaminophen | 14 | $116 | $8 |
Money from drug and device companies
$143 in 2025
| 2025 | 1 | 8 | None | $143 |
| 2024 | 1 | 2 | None | $31 |
| 2022 | 1 | 6 | None | $133 |
| 2020 | 1 | 1 | None | $14 |
| 2019 | 1 | 2 | None | $30 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Natrelle Saline-Filled Breast Implants | $143 | 8 payments
|
See all 8 published payments
| Abbvie | Meals · 2025-12-17 | Natrelle Saline-Filled Breast Implants | $25 |
| Abbvie | Meals · 2025-12-09 | Natrelle Saline-Filled Breast Implants | $12 |
| Abbvie | Meals · 2025-11-26 | Natrelle Saline-Filled Breast Implants | $16 |
| Abbvie | Meals · 2025-11-07 | Natrelle Saline-Filled Breast Implants | $16 |
| Abbvie | Meals · 2025-09-19 | Natrelle Saline-Filled Breast Implants | $11 |
| Abbvie | Meals · 2025-08-06 | Natrelle Saline-Filled Breast Implants | $11 |
| Abbvie | Meals · 2025-07-16 | Natrelle Saline-Filled Breast Implants | $33 |
| Abbvie | Meals · 2025-05-14 | Natrelle Saline-Filled Breast Implants | $19 |
See earlier years (2024, 2022, 2020, 2019)
2024: $31
| Abbvie | Natrelle Saline-Filled Breast Implants | $31 | 2 payments
|
2022: $133
| Allergan | Natrelle Saline-Filled Breast Implants | $133 | 6 payments
|
2020: $14
| Allergan | Natrelle | $14 | 1 payment
|
2019: $30
| Allergan | Botox Cosmetic | $30 | 2 payments
|
Professional record
- NPI
- 1346337946
- Licence
- CA A84319California A84319: Current · expires 2028-10-31
- Trained
- Georgetown University School of Medicine, 1996
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Plastic and reconstructive surgery (2086S0122X)
- Mailing address
- 2350 W El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2006-10-06
- NPI last updated
- 2011-12-06
This is when the NPI record was last certified, not a medical board exam.